ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Politics

Japan to slash price of costly cancer drug early

Ono Pharmaceutical's Opdivo is a highly effective but extremely expensive cancer treatment drug.

TOKYO -- Aiming to curb rising medical costs, the Japanese health ministry has decided to lower the government-sanctioned price of an expensive cancer treatment a year before its regular review.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more